We've found
15,419
archived clinical trials in
Pulmonary
We've found
15,419
archived clinical trials in
Pulmonary
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Updated: 2/13/2018
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter, Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-5 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer)
Status: Enrolling
Updated: 2/13/2018
Click here to add this to my saved trials